Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1641 1644 1671
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17615949 | ANTI-TNF ANTIBODY COMPOSITIONS, AND METHODS FOR THE TREATMENT OF PSORIATIC ARTHRITIS | Final Rejection | Janssen Biotech, Inc. |
| 19297947 | FC FRAGMENTS THAT BIND FCRN AND METHODS OF USE | Final Rejection | Paragon Therapeutics, Inc. |
| 18249708 | INJECTABLE HYDROGELS FOR ADOPTIVE CELL THERAPY | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18013864 | METHODS TO GLYCOENGINEER PROTEINS | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 18163374 | ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND USE IN THERAPY | Non-Final OA | THE TRUSTEES OF DARTMOUTH COLLEGE |
| 18033907 | GENETICALLY ENGINEERED ANTIGEN-SPECIFIC NATURAL KILLER CELLS FOR IN SITU SYNTHESIS OF PROTEINS | Non-Final OA | SRI International |
| 18269257 | Method for Measuring Target Antigen, and Insoluble Particles and Kit for Target Antigen Measurement Used Therein | Non-Final OA | Denka Company Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy